Abstract:Background Gut microbiota profiles are closely related to cardiovascular diseases through mechanisms that include the reported deleterious effects of metabolites, such as trimethylamine N-oxide (TMAO), which have been studied as diagnostic and therapeutic targets. Moderate red wine (RW) consumption is reportedly cardioprotective, possibly by affecting the gut microbiota. Objective To investigate the effects of RW consumption on the gut microbiota, plasma TMAO, and the plasma metabolome in males with documented coronary artery disease (CAD) using a multiomics assessment in a crossover trial. Methods We conducted a randomized, crossover, controlled trial involving 42 males (average age, 60 years) with documented CAD comparing 3-week RW consumption (250 mL/day, 5 days/week) with an equal period of alcohol abstention, both preceded by a 2-week washout period. The gut microbiota was analyzed via 16S rRNA high-throughput sequencing. Plasma TMAO was evaluated by liquid chromatography coupled with mass spectrometry (LC-MS/MS). The plasma metabolome of 20 randomly selected participants was evaluated by ultra-high-performance LC-MS/MS. The effect of RW consumption was assessed by individual comparisons using paired tests during the abstention and RW periods. Results Plasma TMAO did not differ between RW intervention and alcohol abstention, and TMAO levels showed low intraindividual concordance over time, with an intraclass correlation coefficient of 0.049 during the control period. After RW consumption, there was significant remodeling of the gut microbiota, with a difference in beta diversity and predominance of Parasutterella, Ruminococcaceae, several Bacteroides species and Prevotella. Plasma metabolomic analysis revealed significant changes in metabolites after RW consumption, consistent with improved redox homeostasis. Conclusions Modulation of the gut microbiota may contribute to the putative cardiovascular benefits of moderate RW consumption. The low intraindividual concordance of TMAO presents challenges regarding its role as a cardiovascular risk biomarker at the individual level. This study was registered at clinical trials.gov, NCT03232099.

Red Wine High-Molecular-Weight Polyphenolic Complex: an Emerging Modulator of Human Metabolic Disease Risk and Gut Microbiota

Red Wine High-Molecular-Weight Polyphenolic Complex Ameliorates High-Fat Diet-Induced Metabolic Dysregulation and Perturbation in Gut Microbiota in Mice

Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.

Sulfur dioxide-free wine with polyphenols promotes lipid metabolism via the Nrf2 pathway and gut microbiota modulation

Functional components of Chinese rice wine can ameliorate diabetic cardiomyopathy through the modulation of autophagy, apoptosis, gut microbiota, and metabolites

Anti-Diabetic Activity Phenolic Constituents From Red Wine Against Alpha-Glucosidase And Alpha-Amylase

Beneficial Effects of Red Wine Polyphenols on Human Health: Comprehensive Review

Wine’s Phenolic Compounds and Health: A Pythagorean View

Hovenia dulcis Fruit Peduncle Polysaccharides Reduce Intestinal Dysbiosis and Hepatic Fatty Acid Metabolism Disorders in Alcohol-Exposed Mice

Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats

In Vitro and In Silico Interaction Studies with Red Wine Polyphenols against Different Proteins from Human Serum

A red wine intervention does not modify plasma trimethylamine N-oxide but is associated with broad shifts in the plasma metabolome and gut microbiota composition

Anthocyanins-rich purple potato extract prevents low-grade chronic inflammation-associated metabolic disorders

Deciphering the interactions between lipids and red wine polyphenols through the gastrointestinal tract

Effect of moderate red wine consumption on the development and progression of metabolic syndrome as a complex risk factor for cardiovascular disease and diabetes mellitus II.

The Pro-Oxidant Activity of Red Wine Polyphenols Induces an Adaptive Antioxidant Response in Human Erythrocytes

Red Wine Consumption and Cardiovascular Health

Red Wine and Health: Approaches to Improve the Phenolic Content During Winemaking

Cabernet sauvignon dry red wine ameliorates atherosclerosis in mice by regulating inflammation and endothelial function, activating AMPK phosphorylation, and modulating gut microbiota

Pueraria lobata- Prunus mume Complex Alleviates Alcoholic Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation: A Transcriptome and Gut Microbiota Analysis

Basic constituents, bioactive compounds and health-promoting benefits of wine skin pomace: A comprehensive review